Navigation Links
Therapure Biopharma Inc. signs fill/finish contract with Kane Biotech Inc.
Date:3/29/2010

Therapure will provide fill/finish services to support product development.

Toronto, ON (Vocus) March 29, 2010 -- Therapure Biopharma Inc. today announced a fill/finish contract with Kane Biotech Inc. (V.KNE), a Canadian biotechnology company based in Winnipeg, Manitoba. Under the terms of the agreement, Therapure will provide custom fill/finish services for a key development-stage product for Kane Biotech. Financial terms were not disclosed.

Kane Biotech is a biotechnology company engaged in the development of products to prevent and disperse biofilms. Biofilms are a major cause of a number of serious medical problems including chronic infections and medical device related infections. Biofilms develop on surfaces such as catheters, prosthetic implants, teeth, lungs and the urogenital tract. Biofilms are pervasive, costly to deal with and approximately 80% of all human bacterial infections involve biofilms. The healing of chronic wounds alone costs the US health care system $20 billion per year.

“Therapure has signed a variety of fill/finish contracts recently, demonstrating the flexibility of our Health Canada licensed facility” said Thomas Wellner, President and CEO of Therapure. "Our agreement with Kane Biotech includes hand-fill services conducted under Good Manufacturing Practices standards," continued Mr. Wellner.

"Therapure was quick to provide a detailed service proposal that clearly indicated they understood our requirements," said Gord Froehlich, President and CEO of Kane. "We look forward to working closely with Therapure as we advance out products through the approval process," Mr. Froehlich concluded.

About Therapure Biopharma Inc.:
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market for its clients. Therapure’s Health Canada licensed 130,000 sq. ft. facility, includes manufacturing, research and quality control laboratories and a cGMP warehouse, and is built to U.S. FDA, EMEA, MHRA and Health Canada standards for the aseptic handling and purification of proteins.

For more information, please visit: www.therapurebio.com

Company Contact:
Thomas Wellner, President and CEO
Therapure Biopharma Inc.
+1 905 286-6204
ceo (at) therapurebio (dot) com

###

Read the full story at http://www.prweb.com/releases/ContractManufacture/FillFinish/prweb3796474.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Therapure Biopharma Inc. signs multi-year manufacturing agreement with LFB Biomedicaments
2. Therapure Biopharma Inc. Commissions its Commercial-Scale Lyophilizer
3. Microbix and Therapure Biopharma Form Partnership to Expand Water-Based Supplies to the Pharma Industry
4. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
5. Therapure Biopharma Inc. and Akorn, Inc. Announce Strategic Supply Contract
6. PDL BioPharma Announces Two $0.50 Dividends in 2010
7. Seven More Biopharmaceutical Research Companies Join PhRMA
8. BioProcess International Launches a New and Improved Website for Biopharmaceutical Managers and Scientists
9. Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009
10. New Polycarbonate Sign Face Material Eliminates Hot Spots, Optimizes Light Uniformity in LED Back-Lit Signs
11. President Signs Health Reform Bill that Aids Small Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson Insurance ... insurance and financial preparation services, is providing an update on a charitable event ... Rock City Rescue is a locally recognized nonprofit that provides shelter and care ...
(Date:10/13/2017)... ... 2017 , ... While it’s often important to take certain medications during the ... Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL ... it eliminates the need to turn on a light when taking medication during the ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International ... promote standards of excellence for the field of eating disorders, announces the opening ... 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... ... , ... Apple Rehab Shelton Lakes , which specializes in the delivery ... as part of a disaster drill on October 3rd. , Apple Rehab participated with ... Manager, as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
Breaking Medicine Technology: